Recent studies suggest a close relationship between renal dysfunction and new onset diabetes (NOD). The aim of the study was to investigate the association between subclinical functional and structural renal abnormalities and NOD in primary hypertension (PH). This observational prospective study (9.1±2.2 years follow-up) includes 231 consecutive untreated nondiabetic patients with PH and without overt nephropathy. The primary end point was NOD. Albuminuria (albumin to creatinine ratio, ACR), glomerular filtration rate (eGFR), and renal structure and hemodynamics (ultrasound scan and Doppler) were evaluated at baseline. During 2106 person-years of follow-up, 10 patients developed diabetes (incidence rate 4.7/1000 personyears). Patients with NOD showed a higher body mass index, serum uric acid, serum creatinine and ACR, and lower eGFR and renal volume (RV) to resistive index (RI) ratio (RV/RI) at baseline, as compared with the 221 controls that did not develop diabetes. When all renal variables were taken into consideration, RV/RI was the only variable significantly related to diabetes (hazard ratio 1.04, P ¼ 0.0342). Patients in the lowest tertile of RV/RI were more likely to develop diabetes (10.4 vs 2.6 vs 0%, P ¼ 0.0044). For each s.d. decrease of RV/RI, the risk of NOD increased by 68% (P ¼ 0.0012). Subclinical functional and structural renal abnormalities are independent predictors of diabetes in PH.
INTRODUCTION
The alarming increase in the incidence of diabetes and the consequent social and economic burden on public health services call for greater efforts to prevent or delay this condition. Developing new, simple markers to be used in clinical practice is therefore a crucial issue. Patients with hypertension are a subgroup at an increased risk of developing diabetes, nevertheless the underlying pathogenetic mechanisms have not yet been elucidated.
Longitudinal studies have consistently shown that early signs of renal damage bear an incidence of cardiovascular (CV) events that is even greater than that of end stage renal disease. 1 The association between impaired renal function and unfavorable CV outcome is due, at least in part, to the relationship between renal damage and increased incidence of diabetes.
Although elevated urinary albumin excretion has been considered mostly a consequence of diabetes, several findings have recently suggested that urinary albumin excretion may also precede and predict the development of type 2 diabetes. 2 --5 Furthermore, decreases in glomerular filtration rate (eGFR) have recently been linked to insulin resistance 6 and future development of diabetes. 7, 8 Finally, in addition to being a wellknown concomitant of metabolic syndrome (MS), mild hyperuricemia has been proposed as a marker of decreased kidney function. Recent studies have also suggested that increased serum uric acid (SUA) levels are associated with excessive risk of incident type 2 diabetes in the general population 9 and in primary hypertension (PH), regardless of the presence of MS and other potential confounders. 10 The increasing evidence indicating common pathogenetic mechanisms between renal damage and type 2 diabetes prompted us to look at early kidney abnormalities as potential predictors of diabetes in patients with PH.
SUBJECTS AND METHODS

Patient population
A total of 231 consecutive, untreated patients with PH attending the outpatient clinic of our institution were included in the present study. Recruitment took place between January 1997 and June 1999; median follow-up was 9.1 years ( ± 2.2).
Exclusion criteria were: age o18, evidence of neoplastic, hepatic, and/or renal disease (defined as serum creatinine X124 mmol l À1 in males and X106 mmol l À1 in females or overt proteinuria), chronic heart failure (New York Heart Association (NYHA) class III and IV), diabetes (presence of hypoglycemic drugs or fasting plasma glucose X7.0 mmol l À1 ), severe obesity (defined as body weight 4150% of ideal body weight), severe hypertension (X180/110 mm Hg) and disabling diseases such as dementia or the inability to cooperate. Out of 295 patients seen at our clinic within the above-mentioned time range, 274 (all Caucasian Europeans) fulfilled the inclusion criteria and agreed to participate in the study.
Hypertension was defined as an average blood pressure (BP) X140/ 90 mm Hg on at least three different occasions, or by the presence of antihypertensive treatment.
Essential hypertension was diagnosed by the attending physician once complete medical history, physical examination and routine biochemical analyses of blood and urine had been obtained from each patient. Further investigation was carried out only when abnormalities were found in these analyses, or when other symptoms or signs suggesting secondary hypertension were present. MS was defined according to the National Cholesterol Education Program Adult treatment Panel III, 11 and uric acid was not a major criterion. As waist circumference measurements were only available for a subset of participants, we replaced abdominal obesity with overall adiposity, defined as a body mass index (BMI) X30 kg m À2 . In patients with fasting serum glucose X6.1 mmol l À1 (n ¼ 15), a standard 75-g oral glucose-tolerance test was performed. If analyses yielded a diagnosis of secondary hypertension (n ¼ 1), or diabetes (n ¼ 2), subjects were removed from the study. None of the patients showed evidence or history of congestive heart failure, ischemic cardiopathy or advanced chronic obstructive pulmonary disease. Data regarding the patients (n ¼ 37) who either did not comply with washout instructions (15 patients), failed to collect urine samples properly (12 patients) or had to resume medication because of severe hypertension during the washout period (10 patients) were excluded from analysis. Two patients were excluded because of hypokalemia and one because of macroalbuminuria. Thus, the analytic cohort of the present study includes 231 subjects. Attendance was voluntary, and each participant provided written informed consent. All surveys were approved by the Ethics Committee of our Institution. None of the patients were on medication at the time of the study. They either had never been treated (83%, n ¼ 192) or had been taken off therapy at least 4 weeks prior to the study (17%, n ¼ 39).
Baseline measures
During the baseline visit, at the end of the washout period, if any, height, weight, BP values, family history and lifestyle habits were recorded. BP was measured by a trained nurse, with the patient in the sitting position after a 5-min rest, using a mercury sphygmomanometer. The average of three consecutive readings was recorded. Venous blood was drawn after an overnight fast, and albuminuria was evaluated by measuring the urinary albumin to urinary creatinine ratio (ACR). The mean of three nonconsecutive first morning samples was recorded. Only samples from patients with negative urine cultures were collected. The urine albumin concentration was measured using a commercially available radioimmunoassay kit (Pantech, Torino, Italy). Microalbuminuria was defined as an ACR of X2.5 mg mmol À1 in men and an ACR of X3.5 mg mmol À1 in women. eGFR using the Chronic Kidney Disease Epidemiology Collaboration equation. 12 MS was defined according to the National Cholesterol Education Program Adult treatment Panel III. 11 As waist circumference measurements were only available for a subset of participants, we replaced abdominal obesity with overall adiposity, defined as a BMI X30 kg m
À2
. The presence of cardiac and atherosclerotic large vessel damage was assessed by ultrasound (US) techniques.
Renal US and Doppler studies
Renal volume (RV) was measured by use of the ellipsoid formula (volume ¼ length Â width Â thickness Â p/6). The mean of the two kidney volumes for each patient was taken into consideration and corrected for BMI. 13 Doppler signals were obtained from the interlobar arteries. Mean resistive index (RI) ((peak systolic velocityÀend diastolic velocity)/peak systolic velocity) was calculated by using six measurements (three from each of the two kidneys) taken for each patient. US examination of the kidneys and pulsed Doppler of the intrarenal arteries were performed using a Hitachi AU 450 machine (Hitachi, Tokyo, Japan) with a 3.5-MHz transducer working at 2.5 MHz for Doppler analysis. The RV to RI ratio (RV/RI) was used as an expression of nephroangiosclerosis.
Clinical outcome
The primary end point was the development of type 2 diabetes. After baseline evaluation, patients were treated on the basis of current guidelines by the referring general practitioner or specialist, until censoring. The number of events that occurred between baseline examination and the censoring date (17 June, 2006 ) for living persons, or the date of death for fatal events were analyzed. Data concerning life status, causes of death and hospitalization were collected by examining the records of the Nominative Cause of Death Registry, the Hospitalization Discharge Records and the Ligurian Resident Population Registry. As three subjects had moved out of town, information on vital status was obtained from their new local municipalities. The completeness of case findings from the sample was 498%. When an event was reported, original source documents were retrieved. 
Statistical analyses
Data are expressed as mean ± s.d., with the exception of skewed variables, which are expressed as the median and interquartile range. Logarithmically transformed values of skewed variables were used for the statistical analysis. The degree of association between variables was assessed using Pearson's correlation coefficient (r).
Comparisons between groups were made by analysis of variance. Comparisons of proportions among groups were made using the w 2 test or Fisher's exact test when appropriate. Cox proportional hazard regression was used to estimate the hazard ratio (HR) and 95% confidence intervals (CI) for the relationship between several variables and diabetes. Renal parameters and MS were considered possibly related to the development of diabetes and were included in the multivariate models. The final model for the optimal prediction of diabetes included variables that differed significantly among RV/RI tertiles and was fitted by backward elimination of insignificant baseline variables (PX0.05). Statistical analyses were performed using Statview for Windows (version 5.0.1; SAS Institute Inc., Cary, USA). Values of Po0.05 were considered statistically significant.
RESULTS
The study cohort was composed of 231 hypertensive patients aged 48 ± 9 years (median 48 years) with neither diabetes, prior CV events or overt nephropathy. During 2106 person-years of follow-up, 17 patients died of all cause, 16 of CV diseases and 10 developed type 2 diabetes; the incidence rate was 8.0, 7.6 and 4.7/1000 person-years, respectively.
Despite having similar fasting serum glucose and BP levels and lipid profile, predictably, patients who developed diabetes over the follow-up period showed a higher number of MS components (1.57 ± 0.9 vs 0.60 ± 0.79, P ¼ 0.0018) and were more likely to fulfill criteria for the diagnosis of MS at baseline (60 vs 14%, P ¼ 0.0002). Moreover, they showed higher BMI, SUA, serum creatinine, and ACR and lower eGFR baseline levels as compared with the 221 controls who did not develop diabetes ( Table 1) . As for hypertensive organ damage, patients with new onset diabetes (NOD) over the follow-up showed higher left ventricular mass index, carotid intima-media thickness and lower RV/RI ratio at baseline (Table 1) . We investigated the role of several potential risk factors for the development of NOD. MS (HR 1.90, 95%CI 1.60 --1.98, P ¼ 0.0014), BMI (HR 1.37, 95%CI 1.11 --1.69, P ¼ 0.0030), microalbuminuria (HR 4.36, 95%CI 1.21 --15.61, P ¼ 0.0235), ACR (HR 1.15, 95%CI 1.04 --1.26, P ¼ 0.0065), SUA (HR 1.82, 95%CI 1.21 --2.74, P ¼ 0.0037), reduction in eGFR (HR 1.06, 95%CI 1.01 --1.11, P ¼ 0.0202) and RV/RI (HR 1.04, 95%CI 1.02 --1.07, P ¼ 0.0012) were all significantly associated with the occurrence of diabetes.
The relationship between renal parameters and development of diabetes was further investigated by Cox analysis, and only RV/RI showed an independent relationship to the end point (Table 2) .
Univariate analysis showed that among the whole study group, RV/RI was inversely related to BMI (r ¼ À0.63, Po0.0001), age (r ¼ À0.19, P ¼ 0.0052), triglycerides (r ¼ À0.23, P ¼ 0.0008), total cholesterol (r ¼ À0.15, P ¼ 0.0222), pulse pressure (r ¼ À0.22, P ¼ 0.0008), left ventricular mass index (r ¼ À0.27, P ¼ 0.0001) and presence of MS (r ¼ À0.21, P ¼ 0.0022), whereas it was directly related to diastolic BP (r ¼ 0.16, P ¼ 0.0176) and eGFR (r ¼ 0.17, P ¼ 0.0133). Moreover, baseline RV/RI was associated with the presence of diabetes at follow-up in the whole cohort (r ¼ À0.22, P ¼ 0.0009). Table 3 shows baseline clinical characteristics of study patients on the basis of RV/RI ratio tertiles. There was a trend toward higher age, BMI, pulse pressure levels and LVMI, worse lipid profile, lower diastolic BP and eGFR with decreasing tertiles of RV/RI. The baseline prevalence of MS and the incidence of NOD increased progressively from the upper to the lower tertile. Moreover, in the best final model for prediction of NOD according to variables that differed among RV/RI tertiles, only the presence of MS and decrease in eGFR and RV/RI showed an independent relationship with type 2 diabetes (Table 4) .
DISCUSSION
In the present prospective study, we found that subclinical functional and structural renal abnormalities are predictors of NOD in PH. This association is true for albuminuria, SUA, eGFR, and US and renal Doppler abnormalities. Thus, it appears that kidney abnormalities are sensitive predictors of NOD in PH. Noteworthy, in a model including all the renal parameters, RV/RI was the only significant independent risk factor for the development of diabetes over the study period.
Several reports have shown that renal RI calculated by using duplex Doppler US is a useful marker for the presence of nephropathy, and correlates well with histopathological characteristics, particularly arteriolosclerosis, interstitial fibrosis and tubular atrophy.
14 It has been hypothesized that an increase in RI reflects an overall lesser compliance of the vasculature in patients with type 2 diabetes and in patients with PH. In fact, it has been shown that RI correlate with early signs of hypertensive organ damage 15 and of arterial stiffness. 16 Moreover, progressive renal damage is associated with interstitial fibrosis, loss of glomeruli, and a subsequent reduction of the renal vascular area and increment of intrarenal RI. It has, therefore, been proposed that RV/RI might help identify patients with preclinical renal chronic ischemia, characterized by reduced kidney volume and increased renovascular impedance. 17, 18 Interestingly, increased pulse pressure 19 and central aortic pressure index 20 have been shown to predict NOD in high risk and uncomplicated hypertensive patients, respectively. These data are in agreement with the relationship between intrarenal vascular stiffness and the development of diabetes we described. In fact, increased arterial stiffening may lead to small vessel degeneration 21 both at the systemic and intrarenal level, and may generate impaired glucose metabolism mediated by changes in muscle perfusion. An association between micro-and macroangiopathy and insulin resistance, the forerunner of type 2 diabetes, is observed years before the onset of overt disease. Recently, RI has independently and positively been related with insulin resistance, both in newly diagnosed essential hypertension and in type 2 diabetes patients. 22 These findings fit well with data reported here, indicating that RV/RI predicts NOD. In fact, reduced RV/RI could be a marker of systemic small vessel atherosclerosis, which in turn has a role in the development of insulin resistance and consequently of diabetes. Furthermore, RV/RI may signal the presence of subclinical renal dysfunction directly affecting the glucose metabolism, thus leading to the development of diabetes.
As for SUA and eGFR, the relationship between these parameters of renal function and diabetes is well described in the literature. 6 --10 In the present report, both variables showed a predictive role in the development of diabetes. Nevertheless, in multivariate models, their independent role disappears ( Table 2) . Although RI values as such were not related to the development of diabetes, a significant association was found after correction for RV. For each 27 ml m 2 kg (s.d.) decrease in RV/RI our study patients showed an almost 70% greater risk of developing NOD along the study period even taking into consideration several confounding factors (Tables 2 and 4 ). Although the relationship between RI and RV and its modifications over the course of nephroangiosclerosis is currently unclear, overt hypertensive renal damage is known to be characterized by opposite changes in both these variables (that is, decreased RV and increased RI). Thus, our results suggest that the prognostic power of early kidney abnormalities toward NOD integrate and exploit the predictive value of vascular stiffness and insulin resistance. Our study has some limitations, such as the lack of information about family history of diabetes, the type of treatment over the follow-up period. Moreover, the relatively small number of events reported in the present study may have limited the statistical power of our findings. Nevertheless, the incidence of type 2 diabetes was found to be 4.7/1000 person-years, a figure that is in line with what has been described in other studies performed in nearby geographical areas and on subjects with clinical characteristics similar to our study patients. 23, 24 (http://www. osservatorioarno.cineca.org) Finally, we did not directly measure parameters of insulin resistance.
In conclusion, the results of the present study suggest a role for subclinical functional and structural renal abnormalities in the pathogenetic mechanisms leading to the development of diabetes, possibly through peripheral arterial stiffness and insulin resistance.
Furthermore, our data may provide new insight into the complex relationship between renal damage and CV risk. The association between diabetes and renal abnormalities might help explain the pathophysiological processes underlying the occurrence of CV complications in patients with early signs of renal damage, and might account for the worse CV prognosis observed in these patients.
